Toxicokinetics of phenolphthalein in male and female rats and mice

Toxicological Sciences

Volumn 56, Issue 2, 2000, Pages 271-281

  Collins, B J ^a   Grizzle, T B ^b   Dunnick, J K ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Triangle Pharmaceuticals   (United States)

Author keywords

AUC; Feed; Gavage; Iv; Mouse; Multiple routes; Phenolphthalein; Phenolphthalein glucuronide; Rat; Toxicokinetics

Indexed keywords

PHENOLPHTHALEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; FEMALE; MALE; NONHUMAN; RAT; SEX DIFFERENCE; TOXICOKINETICS;

EID: 0033931561     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/56.2.271     Document Type: Article

References (18)

1. Anand, B. S., Torres, E., Operkun, A., and Graham, D. Y. (1994). Comparative assessment of phenolphthalein and phenolphthalein glucuronide: Is phenolphthalein glucuronide a better laxative. Aliment. Pharmacol. Ther. 8, 559-562.
2. Clark, A. G., and Cooke, R. (1978). The effect of route of administration on the biliary excretion of phenolphthalein and its glucuronide. J. Pharm. Pharmacol. 30, 382-383.
3. Colburn, W. A., Hirom, P. C., Parker, R. J., and Milburn, P. (1979). A pharmacokinetic model for enterohepatic recirculation in the rat: Phenolphthalein, a model drug. Drug Metab. Dispos. 7, 100-102.
4. Dunnick, J. K., and Hailey, J. R. (1996). Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Res. 56, 4922-4926.
5. Dunnick, J. K., Hardisty, J. F., Herbert, R. A., Seely, J., Furedi-Machacek, E., Foley, J. F., Lacks, G. J., Stasiewicz, S., and French, J. E. (1997). Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice. Toxicol Pathol. 25, 533-540.
6. FDA (U.S. Food and Drug Administration) (1997). U. S. Food and Drug Administration Laxative Drug Products for Over-the-Counter Human Use; Proposed Amendment to the Tentative Final Rule [Docket No. 78N-036L]. U.S. Food and Drug Administration, 46223-46227.
7. FDA (U.S. Food and Drug Administration) (1998). U. S. Food and Drug Administration Laxative Drug Products for Over-the-Counter Human Use; Proposed Amendment to the tentative final monograph [Docket No. 78N-036]. 33592-33595.
8. Griffin, R. J., Godfrey, V. B., and Burka, L. T. (1998). Metabolism and disposition of phenolphthalein in male and female F344 rats and B6C3F1 mice. Toxicol. Sci. 42, 73-81.
9. Kok, R. M., and Faber, D. B. (1981). Qualitative and quantitative analysis of some synthetic, chemically acting laxatives in urine by gas chromatography-mass spectrometry. J. Chromatogr. 222, 389-398.
10. Morotomi, M., Nanno, M., Watanabe, T., Sakurai, T., and Mutai, M. (1985). Mutagenic activation of biliary metabolites of 1-nitropyrene by intestinal microflora. Mutat. Res. 149, 171-178.
11. NTP (National Toxicology Program) (1996). Toxicology and carcinogenesis studies of phenolphthalein (CAS No. 77-09-8) in F344/N rats and B6C3F1 mice (feed studies). National Toxicology Program; Report Number 465.
12. PDR. (Physicians' Desk Reference) (1982). Physicians' Desk Reference for Nonprescription Drugs. Medical Economics Company Inc., Oradell, NJ.
13. PDR. (Physicians' Desk Reference) (1991). Physicians' Desk Reference. Medical Economics Company Inc., Oradell, NJ.
14. Sipes, H. J., Jr., Corbett, J. T., and Mason, R. P. (1997). In vitro free radical metabolism of phenolphthalein by peroxidases. Drug Metab. Dispos. 25, 468-480.
15. Sparacino, C. M., and Handy, R. W. (1996). Bulk chemical comprehensive analysis report: phenolphthalein. RTI Project No. 60U-6430-071. Research Triangle Institute, Research Triangle Park, NC.
16. Tice, R. R., Furedi-Machacek, M., Satterfeld, D., Udumudi, A., Vasquez, M., and Dunnick, J. K. (1998). Genotoxicity of chronically ingested phenolphthalein in female heterozygous TSG-p53 mice. Environ. Mol. Mutagen. 31, 113-124.
17. Welling, P. G. (1986). Pharmacokinetics. American Chemical Society, Washington, DC.
18. Yuan, J. H. (1993). Modeling blood/plasma concentrations in dosed feed and dosed drinking water toxicology studies. Toxicol. Appl. Pharmacol. 119, 131-141.